BiTEs better than CAR T cells

od Subklewe, Marion
Wydane w Blood Adv (2021)

Chimeric Antigen Receptor T Cells: A Race to Revolutionize Cancer Therapy

od Subklewe, Marion, von Bergwelt-Baildon, Michael, Humpe, Andreas
Wydane w Transfus Med Hemother (2019)

Ten things the hematologist wants you to know about CAR-T cells

od Böll, Boris, Subklewe, Marion, von Bergwelt-Baildon, Michael
Wydane w Intensive Care Med (2020)

T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments

od Daver, Naval, Alotaibi, Ahmad S., Bücklein, Veit, Subklewe, Marion
Wydane w Leukemia (2021)

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab

od Köhnke, Thomas, Krupka, Christina, Tischer, Johanna, Knösel, Thomas, Subklewe, Marion
Wydane w J Hematol Oncol (2015)

Recent developments in immunotherapy of acute myeloid leukemia

od Lichtenegger, Felix S., Krupka, Christina, Haubner, Sascha, Köhnke, Thomas, Subklewe, Marion
Wydane w J Hematol Oncol (2017)

Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy

od Khaldoyanidi, Sophia, Nagorsen, Dirk, Stein, Anthony, Ossenkoppele, Gerrit, Subklewe, Marion
Wydane w J Clin Oncol (2021)

Immunotherapy in Tumors: Activated T Cells as a New Treatment Modality

od Kobold, Sebastian, Duewell, Peter, Schnurr, Max, Subklewe, Marion, Rothenfusser, Simon, Endres, Stefan
Wydane w Dtsch Arztebl Int (2015)

COVID-19 aus Sicht der Hämatologie und Hämostaseologie

od Spiekermann, Karsten, Subklewe, Marion, Hildebrandt, Martin, Humpe, Andreas, von Bergwelt-Baildon, Michael
Wydane w Transfusionsmedizin - Immunhämatologie · Hämotherapie · Transplantationsimmunologie · Zelltherapie (2021)

Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job

od Schwerdtfeger, Melanie, Benmebarek, Mohamed-Reda, Endres, Stefan, Subklewe, Marion, Desiderio, Vincenzo, Kobold, Sebastian
Wydane w Curr Hematol Malig Rep (2021)

Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8(+) Killer T Cells

od Subklewe, Marion, Paludan, Casper, Tsang, Ming L., Mahnke, Karsten, Steinman, Ralph M., Münz, Christian
Wydane 2001

CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells

od Lichtenegger, Felix S., Mueller, Katharina, Otte, Bettina, Beck, Barbara, Hiddemann, Wolfgang, Schendel, Dolores J., Subklewe, Marion
Wydane 2012

A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application Development

od Schinköthe, Timo, Gabri, Mariano Rolando, Mitterer, Manfred, Gouveia, Pedro, Heinemann, Volker, Harbeck, Nadia, Subklewe, Marion
Wydane w JMIR Public Health Surveill (2020)

Sarcoid-Like Reaction in Non-Hodgkin’s Lymphoma—A Diagnostic Challenge for Deauville Scoring on (18)F-FDG PET/CT Imaging

od Winkelmann, Michael, Rejeski, Kai, Subklewe, Marion, Ricke, Jens, Unterrainer, Marcus, Rudelius, Martina, Kunz, Wolfgang G.
Wydane w Diagnostics (Basel) (2021)

Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients

od Bücklein, Veit, Adunka, Tina, Mendler, Anna N., Issels, Rolf, Subklewe, Marion, Schmollinger, Jan C., Noessner, Elfriede
Wydane w Oncoimmunology (2016)

The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression

od Rohrbacher, Lisa, Brauchle, Bettina, Ogrinc Wagner, Ana, von Bergwelt-Baildon, Michael, Bücklein, Veit L., Subklewe, Marion
Wydane w Front Immunol (2021)

Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission

od Beck, Barbara, Dörfel, Daniela, Lichtenegger, Felix S, Geiger, Christiane, Lindner, Lysann, Merk, Martina, Schendel, Dolores J, Subklewe, Marion
Wydane 2011

T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment

od Schnorfeil, Frauke M., Lichtenegger, Felix S., Emmerig, Katharina, Schlueter, Miriam, Neitz, Julia S., Draenert, Rika, Hiddemann, Wolfgang, Subklewe, Marion
Wydane w J Hematol Oncol (2015)

Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells

od Lichtenegger, Felix S., Rothe, Maurine, Schnorfeil, Frauke M., Deiser, Katrin, Krupka, Christina, Augsberger, Christian, Schlüter, Miriam, Neitz, Julia, Subklewe, Marion
Wydane w Front Immunol (2018)

Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on (18)F-FDG PET/CT

od Winkelmann, Michael, Rejeski, Kai, Unterrainer, Marcus, Schmidt, Christian, Ruzicka, Michael, Ricke, Jens, Rudelius, Martina, Subklewe, Marion, Kunz, Wolfgang G.
Wydane w Eur J Nucl Med Mol Imaging (2020)